These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 12030311)
41. Neuropsychological performance in Alzheimer's disease and vascular dementia: comparisons in a memory clinic population. Baillon S; Muhommad S; Marudkar M; Suribhatla S; Dennis M; Spreadbury C; Munro D; Lindesay J Int J Geriatr Psychiatry; 2003 Jul; 18(7):602-8. PubMed ID: 12833304 [TBL] [Abstract][Full Text] [Related]
42. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia. Paci C; Gobbato R; Carboni T; Sanguigni S; Santone A; Curatola L Neurol Sci; 2006 Feb; 26(6):435-7. PubMed ID: 16601937 [TBL] [Abstract][Full Text] [Related]
43. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276 [No Abstract] [Full Text] [Related]
48. Memory factors in Rey AVLT: Implications for early staging of cognitive decline. Fernaeus SE; Ostberg P; Wahlund LO; Hellström A Scand J Psychol; 2014 Dec; 55(6):546-53. PubMed ID: 25112600 [TBL] [Abstract][Full Text] [Related]
49. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials. Passmore AP; Bayer AJ; Steinhagen-Thiessen E J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632 [TBL] [Abstract][Full Text] [Related]
50. A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia. Di Perri R; Coppola G; Ambrosio LA; Grasso A; Puca FM; Rizzo M J Int Med Res; 1991; 19(4):330-41. PubMed ID: 1916007 [TBL] [Abstract][Full Text] [Related]